SBFM · Sunshine Biopharma Inc.
$1.67
-0.04 (-2.34%)
At close · Jul 24
Market Cap
$8.31M
Shares
5.01M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$36.31M
+4.1%
FY2025
Net Income
-$5.98M
-16.4%
FY2025
Gross Margin
33.76%
+3.2pp
FY2025
Operating Margin
-17.15%
-0.5pp
FY2025
Diluted EPS
-$73.20
+97.9%
FY2024
Operating Cash Flow
-$5.33M
+57.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $35.49M | $36.31M | $34.87M | $24.09M | $4.35M | $228.43K | $71.41K | $21.12K | $0 | $0 | — | — | — | — | — | — | — | |
| $23.79M | $24.05M | $24.2M | $15.75M | $2.65M | $117.83K | $25.85K | $11.05K | $0 | $0 | — | — | — | — | — | — | — | |
| $11.71M | $12.26M | $10.67M | $8.34M | $1.7M | $110.6K | $45.56K | $10.07K | $0 | $0 | — | — | — | — | — | — | — | |
| — | 33.76% | 30.6% | 34.61% | 39.04% | 48.42% | 63.8% | 47.68% | — | — | — | — | — | — | — | — | — | |
| $420.76K | $604.31K | $933.9K | $1.86M | $811.86K | $672.21K | $1728 | $15.2K | $12.8K | $0 | $32.79K | $8657 | $327K | $137.4K | $1829 | $142.65K | $0 | |
| $18.03M | $18.48M | $16.48M | $13.12M | $28.7M | $2.55M | $622.44K | $651.71K | $1.16M | $857.19K | $993.11K | $781.99K | $1.76M | $1.94M | $706.68K | $556.2K | $537.38K | |
| — | $37.76K | $77.01K | $38.45K | — | $58.92K | $58.92K | $13.77K | $14.36K | $6629 | $60.73K | $3772 | $0 | — | — | — | — | |
| — | $332.07K | $223.53K | $149.15K | $25.16K | $12.74K | $14.07K | $13.77K | $49.36K | $6629 | $60.73K | $4251 | $0 | — | — | — | — | |
| -$6.33M | -$6.23M | -$5.81M | -$4.79M | -$27M | -$2.44M | -$576.87K | -$641.64K | -$1.16M | -$857.19K | -$993.11K | -$780.28K | -$1.76M | -$1.94M | -$706.68K | -$556.2K | — | |
| — | -17.15% | -16.67% | -19.86% | -621.33% | -1068.24% | -807.83% | -3037.91% | — | — | — | — | — | — | — | — | — | |
| — | -$5.89M | -$5.59M | -$4.64M | -$26.98M | -$2.43M | -$562.81K | -$627.86K | -$1.11M | -$850.56K | -$932.38K | -$776.03K | -$1.76M | — | — | — | — | |
| — | $0 | $8774 | $137.31K | $39.41K | $328.82K | $168.11K | $115.9K | $143.46K | $104.83K | $34.73K | $307.21K | $140.92K | $6455 | $1272 | — | — | |
| $349.2K | $273.29K | $443.15K | $674.42K | $489.61K | -$10M | -$2.21M | -$436.42K | -$973.66K | -$183.05K | -$2.5M | -$872.63K | -$179.1K | -$555.41K | -$1272 | — | — | |
| -$5.98M | -$5.95M | -$5.37M | -$4.11M | -$26.51M | -$12.44M | — | — | — | — | — | — | — | — | — | — | — | |
| $61.77K | $21.61K | -$234.86K | $395.17K | $233.3K | $0 | $0 | — | — | — | — | — | — | — | — | — | — | |
| -$6.04M | -$5.98M | -$5.13M | -$4.51M | -$26.74M | -$12.44M | -$2.78M | -$1.66M | -$2.16M | -$1.04M | -$3.5M | -$1.65M | -$1.93M | -$2.49M | -$707.95K | -$556.2K | -$537.38K | |
| — | -16.46% | -14.72% | -18.7% | -615.44% | -5444.41% | -3898.74% | -7860.85% | — | — | — | — | — | — | — | — | — | |
| — | -$5.98M | -$5.13M | — | — | -$12.44M | -$2.78M | -$1.66M | -$2.16M | -$1.04M | -$3.5M | — | — | — | — | — | — | |
| -$5.58M | -$5.21M | -$6.66M | -$3.97M | -$26.56M | -$12.46M | -$2.78M | -$1.66M | -$2.16M | -$1.04M | -$3.5M | -$1.65M | -$1.93M | — | — | — | — | |
| USD/shares | — | -$14.40 | -$73.20 | -$3,513.60 | -$35,200.00 | -$95,200.00 | -$54,600.00 | -$3,000.00 | -$14,200.00 | -$400.00 | -$200.00 | -$200.00 | -$600.00 | -$800.00 | -$200.00 | -$400.00 | -$400.00 |
| USD/shares | — | — | -$73.20 | -$3,513.60 | -$35,200.00 | -$95,200.00 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 415.71K | 70.17K | 1282.5 | 759.0434 | 130.6031 | 51.0241 | 546.6407 | 152.3404 | 2181.714 | 21.24K | 6113.9455 | 3306.5829 | 2769.791 | 2488.7567 | 1544.0838 | 1492.7962 |
| shares | — | — | 70.17K | 1282.5 | 759.0434 | 130.6031 | — | — | — | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $3.68M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Drug Manufacturers - Specialty & Generic median 2.24×
EV/EBIT
—
Drug Manufacturers - Specialty & Generic median 34.34×
P/E (TTM)
—
Drug Manufacturers - Specialty & Generic median 20.32×